Sinopharm’s COVID-19 vaccine production capacity to exceed 1 billion in 2021

CGTN published this video item, entitled “Sinopharm’s COVID-19 vaccine production capacity to exceed 1 billion in 2021” – below is their description.

For more:

https://news.cgtn.com/news/2021-02-22/Sinopharm-s-COVID-19-vaccine-production-to-exceed-1-billion-in-2021-Y5qBk0SQP6/index.html

China National Pharmaceutical Group’s (Sinopharm) production capacity for inactivated COVID-19 vaccines will exceed one billion doses in 2021, accoring to Sinopharm’s Chairman Liu Jingzhen.

Sinopharm has gained attention for its achievements in the battle against COVID-19. It developed nucleic acid test kits within 48 hours, and successfully prepared plasma for COVID-19 patients in severe situations.

It took only 335 days from developing an inactivated vaccine to obtaining the conditional marketing authorization. Up to now, more than 43 million doses of inactivated Sinopharm vaccines have been used worldwide.

CGTN YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

  • A Debate About Banning Handshakes & Hugs Results In A Shocking Revelation! | Good Morning Britain
  • A Debate About Banning Handshakes & Hugs Results In A Shocking Revelation! | Good Morning Britain
  • France travel ban set to further isolate Brazil over coronavirus response
  • France travel ban set to further isolate Brazil over coronavirus response
  • Coronavirus pandemic inflates used car prices as demand skyrockets | 7NEWS
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • Cameroon receives first batch of COVID-19 vaccines from China
  • Nepal starts second phase of vaccination program with Chinese vaccines
  • Leave a Comment